Read More
Source: http://nursing-resource.com/stivarga-rcoloegorafenib-approved-for-colorectal-cancer-treatment/
the beach blood diamond 8 bit google maps kids choice awards 2012 micah true kansas vs ohio state winning mega million numbers
শুক্রবার, ২৮ সেপ্টেম্বর, ২০১২
Stivarga (Rcoloegorafenib) Approved For Colorectal Cancer - Nursing
Stivarga (regorafenib), a multi-kinase inhibitor, has been approved for the treatment of metastatic colorectal cancer that has continued to spread after treatment, the FDA (Food and Drug Administration) informed today. The medication is presented as tablets and taken orally. Stivarga is a compound which was developed by Bayer Health Care and still belongs to the company...
এতে সদস্যতা:
মন্তব্যগুলি পোস্ট করুন (Atom)
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন